๐ฅณThrilled to share that I'm going to
@MDAndersonNews
for Heme/Onc fellowship!! Forever grateful for my family,
#BestMentorEver
@montypal
, many mentors/sponsors & friends who supported me along the way๐
Can't wait to become an official member of the
#Oncology
community!
Starting 2023 with another powerful PD note by
@MarkDSiegel1
celebrating open doors, diversity, and opportunities for all!
"Since 2011, the year I became PD, weโve matched IMGs from ๐ฎ๐ณ๐ฎ๐ท๐ฎ๐ฑ๐ธ๐ฆ๐น๐ท๐ฌ๐ท๐ฎ๐น๐ฆ๐น๐ฉ๐ช๐ฉ๐ฐ๐ท๐บ๐จ๐ด๐ต๐ช๐ง๐ท๐ฒ๐ฝ๐จ๐ฆ. This year, weโre trying for more."
๐
Our hearts are shattered.
The scale of tragedy unfolding in
#Turkey
&
#Syria
after the
#earthquake
is unimaginable.
Thousands in affected regions need help for rescue now & recovery in the months to come.
For donations:
Pls share๐
I often recall the day I emailed
@montypal
for a research position in ๐บ๐ธ as an IM resident in ๐น๐ท in '16 & his reply in 6 min!
With his mentorship/sponsorship. I had opportunities I could've never imagined
Elections open!
#VoteASCO
#VoteMonty
, amazing advocate for pts & trainees!
"Both the primary predictor and the clinical outcome (ie, overall survival) tested bear great potential to be affected by social factors" by
@NazliDizman
&
@AnaVManana
Check out this letter to the editor
@TheLancetOncol
!
#DumaLab
Million thanks to
@ASCO
for creating a space for
#IMG
in
#oncology
!
There is a lot to do to identify and overcome challenges specific to IMGs. Visa issues, residency/fellowship selection process, grantsmanship, mentor/sponsor search and more.
IMGs, allies, mentors and mentees,
๐จSave the date๐จ
June 2nd, 4-6 PM CST, Room S103, McCormick Place
We are super excited to announce the launch of the
@ASCO
#IMG
Community of Practice this upcoming
#ASCO23
.
Join our all-star speakers to discuss barriers & opportunities for IMGs in
#oncology
.
@ASCOPost
๐ Hey, GU cancer researchers!
Donโt miss your chance to share your research with the largest multidisciplinary global audience for GU cancer research.
Submit your
#GU24
abstract by tomorrow, 9/26:
@ASTRO_org
ย
@UroOnc
ย
@wandering_gu
โจ
@ASCO
International Medical Graduates
@IMG
Community of Practice meeting was absolutely awe-inspiring. It was an immense honor to be a part of this remarkable effort !!!
#ASCO23
@IMG_Oncologists
@DrChoueiri
@ZiadBakouny
๐๐A million thanks to our esteemed speakers & audience
While the pubs of prospective efforts with IO-based combinations in further line treatment of
#mRCC
are around the corner, we appreciate the opportunity to publish our retrospective experience with
#pembrolizumab
#axitinib
in โฅ 2nd line.
๐Thanks
@YaleIMed
@YaleCancer
, for
Great presentation by Dr. Padmanee Sharma of
@MDAndersonNews
@AACR
#AACR20
on why PD-1 and PD-L1 inhibitors performed poorly in
#mCRPC
to date and what the next steps should be
Gain early access to
#SITC2020
and complete your registration by Oct. 26. Youโll have the opportunity to establish your profile, visit exhibitors and network in the Connection Lounge two weeks ahead of SITC 2020. REGISTER TODAY:
So incredibly honored to be selected as an
@OncoAlert
rising star! I cordially thank
@montypal
for his endless support and mentorship and the
@OncoAlert
team, especially
@weoncologists
, for this once in a lifetime opportunity ๐๐
As always,
@mattsydes
amazed the audience today
@ASCO
#GU20
with a great 20-minute presentation on clinical impact/relevance and statistical significance/certainty with many must-read references!
Welcome to everyone attending 2023 IKCS: Europe in Edinburgh, kicking off tomorrow! We're so pleased you are joining us for an amazing
#kidneycancer
program. Be sure to use
#IKCSEU23
to follow the discussion from wherever you are!
So true!
@NazliDizman
is a star. When she first came to
@cityofhope
, I always knew she would be my boss one day. Now, after residency at
@YaleIMed
& fellowship at
@MDAndersonNews
, I suppose that day has come โฆ ๐ธ below is me putting up her
#ASCO24
poster.
In this Review,
@montypal
,
@NazliDizman
and Errol J. Philip provide a comprehensive overview of the prognostic and predictive value of genomics in renal cell carcinoma. Currently free to access.
#RCC
Physician-scientists/clinical fellows: apply now for the
@AACR
Molecular Biology in Clinical Oncology Workshop! For over 25 years this workshop has trained this critical cohort of the cancer workforce! Apps due May 11.
#doubledocs
#physicianscientists
๐ฅKicking off
@ASCO
#GU24
one day early with an excellent line up of faculty and fellows at
@Onclive
fellows forum!
โจLooking forward to learning more about everyoneโs research and journey, and connecting with visionaries in the field
@DrChoueiri
@DrRanaMcKay
@OncBrothers
Indeed, we had an absolutely fantastic time filled with reflection, inspiration, and discussions on future directions at
#ASCO24
IMG CoP meeting!
A huge thank you to our presenters, panelists, over 200 attendees, many volunteers, and
@ASCO
for their support! Can't wait for
@kisacakimdir
Bilim ve tฤฑp alanฤฑnda baลarฤฑlฤฑ olmada birbirimize destek olup yol gรถstererek beraber yรผkselmenin รถnemi รงok bรผyรผk.
Bu amaca hizmetleri iรงin
@kisacakimdir
โe sonsuz teลekkรผrler. ฤฐletiลime geรงmek isteyen arkadaลlar, bana twitterโdan ulaลabilirsiniz.
You are so kind
@MichaelLaPelusa
, really grateful for your friendship ๐ Iโd call it โ
@ASCO
โ effect ๐ So many brilliant trainees and insightful and supportive oncologists at
#ASCO24
looking forward to connecting with each other ๐๐
PS: Congrats
@MichaelLaPelusa
and
The โ
@NazliDizman
โ effect: every time you run into her at
@ASCO
#ASCO24
, you are guaranteed to be pleasantly interrupted by (and introduced to) at least one new superstar acquaintance. Grateful to be her co-fellow!
@MDAndersonNews
๐ซLess than 2 weeks until
@ASCO
#GU21
!!
Very excited for witnessing the groundbreaking science, improving outcomes and separating Kaplan-Mayer curves๐งก
Tbh, I am so glad this year is online. I can't wait to see friends and mentors at
#GU22
in SF!
@montypal
@CityofHope_GU
๐จSave the date๐จ
โฐMay 31st, 4-6 PM CST
๐Room S103, McCormick Place
We are super excited to announce the 2nd annual meeting of the
@ASCO
#IMG
Community of Practice this upcoming
#ASCO24
๐
Join our all-star speakers to discuss barriers & opportunities for IMGs in
#oncology
!
Excited to announce! ๐ Mark your calendars for the
@ASCO
#IMG
Community of Practice Meeting at
#ASCO24
๐ฐ๏ธFri 5/31, 4-6 PM CST at Room S103 McCormick Place.
Looking forward to coming together to celebrate IMGs and discuss ways to support each other. Join us!
@ZiadBakouny
๐จSave the date ๐จ
@ASCO
International Medical Graduates Community of Practice Meeting
โฐMay 31st, 4-6 PM CST
๐Room S103, McCormick Place
Join us to discuss barriers & opportunities for IMGs in
#oncology
ASCO IMG CoP ๐
@ASCOPost
#IMG
#MedEd
#MedTwitter
๐จ
#ASCO23
abstracts are now available!
Late-Breaking Abstracts (LBAs) will be released at 7:00 AM CT on the day of scientific presentation at the meeting. Explore this year's research โก๏ธ
#OncTwitter
๐Thanks so much,
@OncoAlert
for selecting me as a rising star๐A great honor to be recognized by
@Oncoalert
that inspires me & many other trainees around the๐
๐It's not possible for me to show my thankfulness in words to the
#BestMentorEver
@montypal
for his endless support ๐
๐ขExcellent presentation by Dr. Arlene Siefke-Radtke
@MDAndersonNews
on the complex topic of biomarkers in
#UrothelialCarcinoma
@ASCO
#ASCO20
Best biomarker for IO=>Response
PD-L1 & FGFR =>Used but limitations still exist & further work needed
๐
๐๐๐๏ธSo proud of you my dear friend
@AmandaNizamMD
; you inspire me everyday!
๐Dear
#MedTwitter
#OncTwitter
, take a moment to appreciate the collaborative and supportive atmosphere captured in this video and the smiles on the faces of leaders in
#GU
#oncology
as they support
With your permission,
@DrChoueiri
, I plan on framing a printout of this tweet for my future office wall๐๐
Your guidance and support over the years have been invaluable. We're incredibly fortunate to have you as a role model and I can't thank
@montypal
&
@ASCO
enough for
This is the tweet that made me burst into tears! Can't thank
@montypal
enough for giving me a chance to follow my dreams 6 years ago and changing my life forever! ๐๐๐
#IMG
#WomenInMedicine
Pleased to share our study showing that while acute kidney injury (AKI) in patients on immune checkpoint inhibitors (ICI) associates with higher mortality, the mortality of AKI from acute interstitial nephritis (AIN) is not higher.
1/
Bright and early at
@ASCO
#ASCO24
today ๐ . Had a fantastic breakfast with the amazing
@NarjustFlorezMD
๐ Truly grateful to have you to turn to for advice ๐ Thanks for the incredible insights!
@Florez_Lab
NO BETTER WAY TO START THE DAY!
Mentorship meeting with the unstoppable Dr.
@NazliDizman
- career paths, grants and work-life integration.
Our mentees should learn from our mistake and grow at a faster pace than we have.
#ASCO24
Huge congrats to my dear friends and colleagues
@ZeynepZengin
and
@LuisMezaco
for this fantastic achievement with the exemplary leadership and mentorship of
#BestMentorEver
@montypal
๐๐๐ IMHO, there is no better place to train than
@YaleIMed
, and I can't wait for these two to
Grateful to have been part of
@SWOG
#DrNickVogelzang
#microbiome
in
#GU
cancers symposium with insightful discussions on awe-inspiring research paving the way for novel microbiome-based interventions.
๐
@montypal
#MichaelLiss
๐ for contributions of all panelist and audience
Words can not express how grateful I'm for
@montypal
@COHMedOnc
for giving me a chance while looking for research opportunities in US ๐บ๐ธ as an IM resident from
#Turkey
๐น๐ท in 2016, & mentoring/supporting & inspiring me w his passion for cancer research for years.
@IMG_Oncologists
Fellowship programs:
@NazliDizman
@YaleIMed
is applying this year! You will never meet a harder working, more driven individual. Thank you
@KidneyCancer
for offering her this amazing opportunity to further her research goals!
@Montypal
never tires of highlighting and praising othersโ work but rarely talks about his own accomplishments๐ THREE back-to-back FIRST author
@TheLancet
papers on original research in the last 3 yrs (2021, 2022, 2023). ๐๐๐Congrats Monty for being such a humble and generous
Unfortunately, visa-related issues are the root cause of many struggles
@IMG_Oncologists
come across.
We got the answers from Susan Saliba, JD in our seminar where we discussed ways to tackle J1 waiver, EB1/2 application, visa denials, travel restrictions & more! Check out!
Could not agree more with
@thenasheffect
@FawziAbuRous
@AminNassarMD
@drsomedeb
!
Visa-related issues are such a barrier to the careers of IMGs.
Weโve uploaded our recent seminar on the topic below, hope you find it helpful. A lot more needs to be done!
Excited to announce that I have taken on the role of Vice Chair of Academic Affairs in the Department of Medical Oncology & Experimental Therapeutics at
@cityofhope
.
Candidly, in my 17 years at this great institution, Iโve been reluctant to take on roles in leadership. Why?
๐จSave the date๐จ
โฐMay 31st, 4-6 PM CST
๐Room S103, McCormick Place
We are super excited to announce the 2nd annual meeting of the
@ASCO
#IMG
Community of Practice this upcoming
#ASCO24
๐
Join our all-star speakers to discuss barriers & opportunities for IMGs in
#oncology
!
Dr. Arlene Siefker-Radtke
@MDAndersonNews
continues to amaze the audience with insightful interpretation of the enfortumab data
@ASCO
#GU21
โ Enfortumab vedotin is here to stay as 3rd L
#mUC
tx w/ level 1 evidence
โผ๏ธ Side effects exist, monitor the caveats
@OncoAlert
๐ฅACIS trial - Oral abstract session
@ASCO
#GU21
by
@DRathkopf
et al
๐ถ Apalutamide + abiraterone vs placebo + abiraterone
n=982 chemo-naive mCRPC
Apa+ Abi
โฌ๏ธrPFS 24 mo vs 16.6 mo
โฌ๏ธOS 36 mo vs 33 mo, p=0.498
Similar HRQL, slightly high AE rates
Moving to
@DanaFarberNews
during a pandemic, after a Dx of thoracic outlet syndrome & in the middle of a divorce was challenging to say the least
Dr.
@DrChoueiri
supported me to overcome these challenges & make DFCI my new home
Vote for this leader at
@ASCO
election!